171 related articles for article (PubMed ID: 22676833)
1. Sunitinib related osteonecrosis of jaw: a case report.
Fleissig Y; Regev E; Lehman H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):e1-3. PubMed ID: 22676833
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaw related to sunitinib.
Koch FP; Walter C; Hansen T; Jäger E; Wagner W
Oral Maxillofac Surg; 2011 Mar; 15(1):63-6. PubMed ID: 20401503
[TBL] [Abstract][Full Text] [Related]
3. Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.
Nicolatou-Galitis O; Migkou M; Psyrri A; Bamias A; Pectasides D; Economopoulos T; Raber-Durlacher JE; Dimitriadis G; Dimopoulos MA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):234-8. PubMed ID: 22669112
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Bozas G; Roy A; Ramasamy V; Maraveyas A
Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.
Hoefert S; Eufinger H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):463-9. PubMed ID: 20692189
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports.
Agrillo A; Nastro Siniscalchi E; Facchini A; Filiaci F; Ungari C
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):952-7. PubMed ID: 22953645
[TBL] [Abstract][Full Text] [Related]
7. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
Brunello A; Saia G; Bedogni A; Scaglione D; Basso U
Bone; 2009 Jan; 44(1):173-5. PubMed ID: 18849018
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature.
Fusco V; Porta C; Saia G; Paglino C; Bettini G; Scoletta M; Bonacina R; Vescovi P; Merigo E; Lo Re G; Guglielmini P; Di Fede O; Campisi G; Bedogni A
Clin Genitourin Cancer; 2015 Aug; 13(4):287-294. PubMed ID: 25586958
[TBL] [Abstract][Full Text] [Related]
9. [Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
Soós B; Vajta L; Szalma J
Orv Hetil; 2015 Nov; 156(46):1865-70. PubMed ID: 26548471
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the jaw in a patient receiving cabozantinib.
Marino R; Orlandi F; Arecco F; Gandolfo S; Pentenero M
Aust Dent J; 2015 Dec; 60(4):528-31. PubMed ID: 25474298
[TBL] [Abstract][Full Text] [Related]
11. Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw.
Troeltzsch M; Woodlock T; Kriegelstein S; Steiner T; Messlinger K; Troeltzsch M
J Can Dent Assoc; 2012; 78():c85. PubMed ID: 22985897
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
[TBL] [Abstract][Full Text] [Related]
13. Acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib.
Gomez-Abuin G; Karam AA; Mezzadri NA; Bas CA
Clin Genitourin Cancer; 2009 Jan; 7(1):62-3. PubMed ID: 19213671
[TBL] [Abstract][Full Text] [Related]
14. Denosumab-related osteonecrosis of the jaw.
Diz P; López-Cedrún JL; Arenaz J; Scully C
J Am Dent Assoc; 2012 Sep; 143(9):981-4. PubMed ID: 22942143
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
Ayllon J; Launay-Vacher V; Medioni J; Cros C; Spano JP; Oudard S
Ann Oncol; 2009 Mar; 20(3):600-1. PubMed ID: 19188135
[No Abstract] [Full Text] [Related]
16. Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab.
Pakosch D; Papadimas D; Munding J; Kawa D; Kriwalsky MS
Oral Maxillofac Surg; 2013 Dec; 17(4):303-6. PubMed ID: 23242941
[TBL] [Abstract][Full Text] [Related]
17. Influence of immediate post-extraction socket irrigation on development of alveolar osteitis after mandibular third molar removal: a prospective split-mouth study, preliminary report.
Tolstunov L
Br Dent J; 2012 Dec; 213(12):597-601. PubMed ID: 23257808
[TBL] [Abstract][Full Text] [Related]
18. Denosumab-associated osteonecrosis of the jaw--a case report.
Vyas S; Hameed S; Murugaraj V
Dent Update; 2014 Jun; 41(5):449-50. PubMed ID: 25073227
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of hypertension in advanced renal cell carcinoma: prospective evaluation of an algorithm in patients treated with sunitinib.
Bamias A; Lainakis G; Manios E; Koroboki E; Gyftaki R; Zakopoulos N; Dimopoulos MA
J Chemother; 2009 Jun; 21(3):347-50. PubMed ID: 19567357
[TBL] [Abstract][Full Text] [Related]
20. Images in clinical medicine. Bisphosphonate-associated osteonecrosis of the jaw.
Treister N; Woo SB
N Engl J Med; 2006 Nov; 355(22):2348. PubMed ID: 17135588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
